Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.

Balki A, Balamurugan S, Bardapurkar S, Dalal S, Singh A, Singh BP, Vaidya A, Gogtay JA

Open source

DOI
10.1016/j.pupt.2017.09.001
Published
2018 Feb
Container
Pulmonary pharmacology & therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pupt.2017.09.001,
  title = {Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.},
  author = {Balki A and Balamurugan S and Bardapurkar S and Dalal S and Singh A and Singh BP and Vaidya A and Gogtay JA},
  year = {2018},
  journal = {Pulmonary pharmacology \& therapeutics},
  doi = {10.1016/j.pupt.2017.09.001},
  url = {https://doi.org/10.1016/j.pupt.2017.09.001}
}

RIS

TY  - JOUR
TI  - Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
AU  - Balki A
AU  - Balamurugan S
AU  - Bardapurkar S
AU  - Dalal S
AU  - Singh A
AU  - Singh BP
AU  - Vaidya A
AU  - Gogtay JA
PY  - 2018
JO  - Pulmonary pharmacology & therapeutics
DO  - 10.1016/j.pupt.2017.09.001
UR  - https://doi.org/10.1016/j.pupt.2017.09.001
ER  - 

APA

A, B., S, B., S, B., S, D., A, S., BP, S., A, V., & JA, G. (2018). Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.. Pulmonary pharmacology & therapeutics. https://doi.org/10.1016/j.pupt.2017.09.001

Source records